EA200300828A1 - Средство против стресса - Google Patents

Средство против стресса

Info

Publication number
EA200300828A1
EA200300828A1 EA200300828A EA200300828A EA200300828A1 EA 200300828 A1 EA200300828 A1 EA 200300828A1 EA 200300828 A EA200300828 A EA 200300828A EA 200300828 A EA200300828 A EA 200300828A EA 200300828 A1 EA200300828 A1 EA 200300828A1
Authority
EA
Eurasian Patent Office
Prior art keywords
present
stress
means against
against stress
stress agent
Prior art date
Application number
EA200300828A
Other languages
English (en)
Inventor
Масахиро Мураками
Сигео Такада
Ясуказу Нагато
Сусуму Окабе
Original Assignee
Амато Фармасьютикал Продактс, Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Амато Фармасьютикал Продактс, Лтд. filed Critical Амато Фармасьютикал Продактс, Лтд.
Publication of EA200300828A1 publication Critical patent/EA200300828A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
    • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Целью настоящего изобретения является представление нового средства против стресса, которое можно применять для подавления стресса. В соответствии с настоящим изобретением представляется средство против стресса, которое включает в себя смесь циклических и/или прямоцепочечных полимолочных кислот, имеющих степень конденсации от 3 до 20.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200300828A 2001-01-24 2002-01-22 Средство против стресса EA200300828A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001016145 2001-01-24
PCT/JP2002/000411 WO2002060457A1 (fr) 2001-01-24 2002-01-22 Agents anti-stress

Publications (1)

Publication Number Publication Date
EA200300828A1 true EA200300828A1 (ru) 2003-12-25

Family

ID=18882568

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300828A EA200300828A1 (ru) 2001-01-24 2002-01-22 Средство против стресса

Country Status (9)

Country Link
US (1) US20040116520A1 (ru)
EP (1) EP1362594A1 (ru)
JP (1) JPWO2002060457A1 (ru)
KR (1) KR20030070137A (ru)
CN (1) CN1518453A (ru)
CA (1) CA2436000A1 (ru)
EA (1) EA200300828A1 (ru)
NO (1) NO20033324L (ru)
WO (1) WO2002060457A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1205201C (zh) 1999-09-20 2005-06-08 天藤制药株式会社 环状乳酸齐聚物的制备方法
TW200303299A (en) * 2002-02-19 2003-09-01 Amato Pharm Prod Ltd Chain oligolactic acid thioester
CA2489592A1 (en) * 2002-06-12 2003-12-24 Amato Pharmaceutical Products, Ltd. Inhibitor of anticancer drug side effect
JP2004175783A (ja) * 2003-04-14 2004-06-24 Yuuko-Enterprise Corp 子宮内膜症及び婦人科疾患の治療薬
MX2009010445A (es) 2007-03-30 2010-01-29 Laccure Ab Uso de oligomeros de acido lactico en el tratamiento de trastornos ginecologicos.
JP2008297204A (ja) * 2007-05-29 2008-12-11 Masahiro Murakami ポリ乳酸混合物を含む肝繊維化の抑制又は改善剤

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0311651A1 (en) * 1987-04-01 1989-04-19 Cellena (Cell Engeneering) A.G. Melatonin-derivatives for psychogenic stress and acute anxiety, and immuno-stimulant drugs
JP3425968B2 (ja) * 1992-05-15 2003-07-14 興研株式会社 人を含む動物の悪性腫瘍細胞増殖抑制剤
JPH06336427A (ja) * 1993-05-26 1994-12-06 Global Art Kk 人を含む動物の悪性腫瘍細胞増殖抑制剤
JPH07233061A (ja) * 1994-02-22 1995-09-05 Global Art Kk 人を含む動物の悪性腫瘍細胞増殖抑制作用を有する経口投与剤の製造方法
ATE420171T1 (de) * 1994-07-15 2009-01-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
JPH09132533A (ja) * 1995-11-10 1997-05-20 Kano Shiyoujiyuan:Kk 乳酸菌発酵物からなる潰瘍抑制剤及び肝臓障害抑制剤
JPH09227388A (ja) * 1996-02-15 1997-09-02 Naganushi Tetsuaki 大腸癌、食道癌及び乳癌より選ばれた癌に用いる抗悪性腫瘍剤
JPH09227400A (ja) * 1996-02-28 1997-09-02 Pola Chem Ind Inc 副腎皮質ホルモン分泌抑制剤
JPH10130153A (ja) * 1996-10-28 1998-05-19 Shiyumeidou:Kk 大腸癌、食道癌及び乳癌より選ばれた癌に用いる 抗悪性腫瘍剤
JPH10203994A (ja) * 1997-01-27 1998-08-04 Ichimaru Pharcos Co Ltd 生理活性作用組成物
JP2000072680A (ja) * 1998-08-25 2000-03-07 Shiyumeidou:Kk 免疫機能調節剤
JP2000086526A (ja) * 1998-09-11 2000-03-28 Lotte Co Ltd 免疫賦活剤およびそれを含有する飲食物
CN1165314C (zh) * 1999-08-09 2004-09-08 天藤制药株式会社 聚乳酸混合物在制备糖尿病治疗剂中的用途
AU7316800A (en) * 1999-09-20 2001-04-24 Amato Pharmaceutical Products, Ltd. Physical strength enhancing agents and glycogen accumulation promoting agents
JP2001139476A (ja) * 1999-11-15 2001-05-22 Youichirou Naganushi 癌を含めた悪性新生物に用いる抗悪性腫瘍剤
US20030072735A1 (en) * 1999-12-03 2003-04-17 Chieko Murayama Radioprotecting agent
WO2001054705A1 (fr) * 2000-01-26 2001-08-02 Amato Pharmaceutical Products, Ltd. Inhibiteurs d'implantation de cellules cancereuses

Also Published As

Publication number Publication date
US20040116520A1 (en) 2004-06-17
WO2002060457A1 (fr) 2002-08-08
NO20033324D0 (no) 2003-07-23
NO20033324L (no) 2003-09-23
JPWO2002060457A1 (ja) 2004-05-27
CN1518453A (zh) 2004-08-04
CA2436000A1 (en) 2002-08-08
KR20030070137A (ko) 2003-08-27
EP1362594A1 (en) 2003-11-19

Similar Documents

Publication Publication Date Title
EA200200858A1 (ru) Фармацевтические композиции, содержащие ингибиторы гликогенфосфорилазы
BR9913517A (pt) Composição, dispositivo, e, uso de uma composição
EA200301115A1 (ru) Кристаллические формы азитромицина
EA200201214A1 (ru) Замещенные тиоацетамиды
EA200500488A1 (ru) Фармацевтические составы модафинила
EA200400284A1 (ru) Антинеопластические комбинации
ATE510534T1 (de) Naltrexonhydrochlorid-zusammensetzungen
BR0200852A (pt) Sistema de câmara de combustão
EA200300377A1 (ru) Производные 2-амино-2-алкил-5-гептеновой и -гептиновой кислот, которые могут быть использованы в качестве ингибиторов синтетазы оксида азота
BR9811839A (pt) Plasma sanguìneo universalmente aplicável
PT1189970E (pt) Aditivo carboxi-funcional para a condensacao de poliamidas
EA200200875A1 (ru) Пролекарства производных имидазопиридина
ATE495247T1 (de) Chromoprotein und fluoroproteine
EA200400254A1 (ru) Трициклические имидазопиридины
EA200300828A1 (ru) Средство против стресса
EA199901113A1 (ru) Карбоксамиды в качестве агонистов 5-ht1f
EA199800844A1 (ru) Способ получения r-альфа-пропил-пиперониламина и его аналогов, промежуточные продукты, используемые в этом способе
EA200300478A1 (ru) Полизамещенные имидазопиридины в качестве ингибиторов желудочной секреции
SE0203555L (sv) Modifierade xylanaser som utövar ökad termofilicitet och alkalofilicitet
EA200500486A1 (ru) Новые фармацевтические составы модафинила
EA200300978A1 (ru) Ингибирование поглощения моноамина
WO2004094465A3 (en) Synthetic molecules that mimic chemokines
PL1603544T3 (pl) Leczenie stanów żołądkowo-jelitowych za pomocą N-2,3,3-tertametylobicyklo2.2.1 heptano-2-aminy
EA200200798A1 (ru) Кальцилитические соединения
EA200001050A1 (ru) Малеат пароксетина